Cargando…

A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

In elderly acute myeloid leukemia (AML) patients post-remission treatment options are associated with high comorbidity rates and poor survival. Dendritic cell (DC)-based immunotherapy is a promising alternative treatment strategy. A novel allogeneic DC vaccine, DCP-001, was developed from an AML-der...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Loosdrecht, Arjan A., van Wetering, Sandra, Santegoets, Saskia J. A. M., Singh, Satwinder Kaur, Eeltink, Corien M., den Hartog, Yvonne, Koppes, Malika, Kaspers, Jorn, Ossenkoppele, Gert J., Kruisbeek, Ada M., de Gruijl, Tanja D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182404/
https://www.ncbi.nlm.nih.gov/pubmed/30039426
http://dx.doi.org/10.1007/s00262-018-2198-9